04/11/23

RAIsonance, Inc. Launches AI-Powered Smoker Recovery App


MyAdvocate Product Tracks Progress Upon Quitting and Delivers a Personalized Biometric Score for Each User’s Respiratory Wellness Journey


April 11, 2023 – RAIsonance, Inc., the leader in artificial intelligence-powered analysis of Forced Cough Vocalization (FCV), today announced the launch of two new apps for iOS and Android mobile devices. The apps, MyAdvocate Smoker Recovery and MyAdvocate Vape Recovery, use AI to support cessation by tracking each user’s personal progress, and providing them with personal biometric cough score analyses that measure their journey back to respiratory health. The apps are free to download on the App Store and Google Play, and specially priced 6-month and 12-month packages can be purchased from the MyAdvocate storefront.


Kicking a nicotine habit is extremely difficult, no matter who you are. On average, people make 5 to 7 attempts to quit before they actually succeed. We created this product because we know that being able to see your personal progress and improvement makes a huge difference in a person’s motivation to keep going, and quit for good. Using artificial intelligence, we can provide users with an incredibly detailed, completely customized understanding of their progress back to health.
-Kitty Kolding, CEO and Co-Founder of RAIsonance, Inc.

In the US, more than 30 million adults smoke cigarettes and more than 2.5 million high school and middle school kids use e-cigarettes. And, at any given moment, approximately 65% of smokers say they want to quit. Recent studies by NIH show that “mobile phone-based interventions, interactive and tailored internet-based interventions, … had modest but significantly increased benefits to smoking cessation at 6 or more months”.


To set up MyAdvocate, the mobile app guides a user through recording several sets of intentional coughs called FCVs. From those recordings, MyAdvocate uses AI to create a baseline - a composite of the user’s FCV signature as unique as their fingerprint. This baseline is a multi-dimensional representation of the imprint representing a user’s respiratory function. With this baseline in place, a user can check their progress any time by coughing again into the app. The MyAdvocate AI compares the current cough to the baseline, and shows an Improvement Score in about 2 minutes, right in the app.


Both apps are designed to work alongside any other smoke or vape cessation products or programs. Similar to dieting, no matter what diet program a person might use, they always use a scale to measure their progress. MyAdvocate is exactly that: the ultimate biometric measure of progress back to health. In testing for more than 2 years, the MyAdvocate FCV tracking technology is the only system that uses AI-powered deep science to track the changes to a user’s unique FCV.


About RAIsonance, Inc.

RAIsonance is a family of companies headquartered in the Denver Tech Center in Colorado, dedicated to Artificial Intelligence/Machine Learning (AI/ML)-based solutions for the safety, security, and healthcare diagnostics markets. Originally funded with a grant from the National Science Foundation, RAIsonance has developed breakthrough technology innovations that use signal data signature recognition as a biomarker for human medical diagnostics and to support ground-breaking safety applications. To learn more about RAIsonance Inc., please visit RAIsonance.ai


RAIsonance Investor Contact:
 Jamie Mariani, CFO
 Email: InvestorRelations@raisonance.ai


RAIsonance Media Contact:
 Denise Covington, VP Marketing
 Email: Press@raisonance.ai